Sign In

Login

Password

Forgot Password ? Sign Up

Pimawanseryna (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Pimawanseryna" in Polish language version.

refsWebsite
Global rank Polish rank
2doi.org
2nd place
6th place
2nih.gov
4th place
7th place
1acadia-pharm.com
low place
low place
1fda.gov
447th place
1,118th place
1nuplazid.com
low place
low place

acadia-pharm.com

doi.org

  • J.H. Friedman. Pimavanserin for the treatment of Parkinson’s disease psychosis. „Expert Opinion on Pharmacotherapy”. 14 (14), s. 1969–1975, 2013. DOI: 10.1517/14656566.2013.819345. PMID: 24016069. 
  • H.Y. Meltzer, H. Elkis, K. Vanover, D.M. Weiner i inni. Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2mg/day, but does not enhance efficacy of haloperidol, 2mg/day: comparison with reference dose risperidone, 6mg/day. „Schizophrenia Research”. 141 (2-3), s. 144–152, 2012. DOI: 10.1016/j.schres.2012.07.029. PMID: 22954754. 

fda.gov

nih.gov

ncbi.nlm.nih.gov

  • J.H. Friedman. Pimavanserin for the treatment of Parkinson’s disease psychosis. „Expert Opinion on Pharmacotherapy”. 14 (14), s. 1969–1975, 2013. DOI: 10.1517/14656566.2013.819345. PMID: 24016069. 
  • H.Y. Meltzer, H. Elkis, K. Vanover, D.M. Weiner i inni. Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2mg/day, but does not enhance efficacy of haloperidol, 2mg/day: comparison with reference dose risperidone, 6mg/day. „Schizophrenia Research”. 141 (2-3), s. 144–152, 2012. DOI: 10.1016/j.schres.2012.07.029. PMID: 22954754. 

nuplazid.com